计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| E126633-100mg |
100mg |
现货 ![]() |
| |
| E126633-500mg |
500mg |
现货 ![]() |
| |
| E126633-1g |
1g |
现货 ![]() |
| |
| E126633-5g |
5g |
现货 ![]() |
| |
| E126633-25g |
25g |
现货 ![]() |
|
| 别名 | 埃罗替尼 |
|---|---|
| 英文别名 | R 1415 | Kinome_3317 | n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride | Tox21_301219 | ERLOTINIB [EMA EPAR] | ERLOTINIB [WHO-DD] | HMS3745M05 | NCGC00164574-01 | HMS3713C22 | Isoproturon [BSI:ISO] | Q27265078 | 4-Quinazol |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Erlotinib |
| 生化机理 | 盐酸厄洛替尼(商品名Tarceva;NSC 718781;OSI 744;R 1415)是一种用于治疗非小细胞肺癌、胰腺癌和其他几种癌症的药物。盐酸厄洛替尼(商品名 Tarceva;NSC 718781;OSI 744;R 1415)是一种可逆性酪氨酸激酶抑制剂,作用于表皮生长因子受体(EGFR)。它在美国由基因泰克公司和 OSI 制药公司销售,在其他国家由罗氏公司销售。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 表皮生长因子受体抑制剂;OATP2B1 抑制剂 |
| 产品介绍 |
Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor.A tyrosine kinase inhibitor Erlotinib, Free Base, is the free base form of erlotinib hydrochloride (sc-202154), a small molecule EGFR/HER-1 (human epidermal growth factor receptor) tyrosine kinase reversible inhibitor. |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504757691 |
|---|---|
| EC号 | 689-196-2 |
| 分子类型 | 小分子 |
| IIUPAC Name | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine |
| INCHI | 1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) |
| InChi Key | AAKJLRGGTJKAMG-UHFFFAOYSA-N |
| Smiles | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC |
| Isomeric SMILES | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC |
| 关联CAS | 183321-74-6 |
| MeSH Entry Terms | 11C erlotinib;11C-erlotinib;358,774, CP;358774, CP;CP 358,774;CP 358774;CP-358,774;CP-358774;CP358,774;CP358774;erlotinib;erlotinib HCl;erlotinib hydrochloride;HCl, Erlotinib;Hydrochloride, Erlotinib;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin- |
| 分子量 | 393.44 |
| Reaxy-Rn | 8798958 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=8798958&ln= |
| 溶解性 | DMSO |
|---|---|
| 折光率 | 1.62 |
| 熔点 | 167-180°C |
| 分子量 | 393.400 g/mol |
| XLogP3 | 3.300 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 11 |
| 精确质量Exact Mass | 393.169 Da |
| 单同位素质量Monoisotopic Mass | 393.169 Da |
| 拓扑极表面积Topological Polar Surface Area | 74.700 Ų |
| 重原子数Heavy Atom Count | 29 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 525.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07, GHS08, GHS09 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H351: 怀疑引起遗传缺陷 H411: 对水生生物有毒并具有长期持续影响 H413: 可能对水生生物造成长期的有害影响 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P330: 漱口 P391: 收集溢出物 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P318: 如果暴露或担心,请就医。 |
| 1. Zhao-Yang Wang, Hai-Long Wu, Yue-Yue Chang, Tong Wang, Wei Chen, Gao-Yan Tong, Ru-Qin Yu. (2021) Simultaneous determination of nine tyrosine kinase inhibitors in three complex biological matrices by using high-performance liquid chromatography–diode array detection combined with a second-order calibration method. JOURNAL OF SEPARATION SCIENCE, 44 (21): (3914-3923). [PMID:34463059] [10.1002/jssc.202100293] |
| 2. Bao Shihui, Zheng Hailun, Ye Jinyao, Huang Huirong, Zhou Bin, Yao Qing, Lin Guangyong, Zhang Hailin, Kou Longfa, Chen Ruijie. (2021) Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. Frontiers in Pharmacology, 12 (138). [PMID:33815107] [10.3389/fphar.2021.625084] |
| 3. Yue-Yue Chang, Hai-Long Wu, Huan Fang, Tong Wang, Yang-Zi Ouyang, Xiao-Dong Sun, Gao-Yan Tong, Yu-Jie Ding, Ru-Qin Yu. (2021) Comparison of three chemometric methods for processing HPLC-DAD data with time shifts: Simultaneous determination of ten molecular targeted anti-tumor drugs in different biological samples. TALANTA, 224 (121798). [PMID:33379025] [10.1016/j.talanta.2020.121798] |
| 4. Yang Lehe, Lin Shichong, Kang Yanting, Xiang Youqun, Xu Lingyuan, Li Jifa, Dai Xuanxuan, Liang Guang, Huang Xiaoying, Zhao Chengguang. (2019) Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 38 (1): (1-13). [PMID:30674340] [10.1186/s13046-018-1015-9] |
| 5. Jingwei Shao, Guirong Zheng, Hongning Chen, Jian Liu, Aixiao Xu, Fan Chen, Tao Li, Yusheng Lu, Jianguo Xu, Ning Zheng, Lee Jia. (2017) Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway. Oncotarget, 8 (45): ( 78351–78364). [PMID:29108234] [10.18632/oncotarget.18640] |
| 6. Qianqian Wang, Yuanyuan Zheng, Bowen Deng, Di Chen, Liuqun Jia, Nian Shi. (2024) Automated kapok fiber-based pipette-tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry for rapid and sensitive analysis of tyrosine kinase inhibitors in plasma. JOURNAL OF CHROMATOGRAPHY A, 1736 (465420). [PMID:39378625] [10.1016/j.chroma.2024.465420] |
| 7. Jing Ye, Yuanyuan Zheng, Xiangyu Li, Xingyi Jiang, Di Chen. (2024) Melt-blown polypropylene nonwoven as an efficient and eco-economic sorbent for pipette tip micro-solid phase extraction for the determination of tyrosine kinase inhibitors. ANALYTICA CHIMICA ACTA, 1329 (343240). [PMID:39396303] [10.1016/j.aca.2024.343240] |
| 8. Qianqian Wang, Yuwei Liu, Yuanyuan Zheng, Di Chen, Ya Xie, Nian Shi. (2024) MonoTip C18 pipette tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry enables rapid and automated therapeutic drug monitoring of tyrosine kinase inhibitors. Arabian Journal of Chemistry, 17 (105976). [10.1016/j.arabjc.2024.105976] |
| 9. Shuangyu Tian, Jinghang Li, Dongdong Wang, Yingchao Han, Honglian Dai, Lesan Yan. (2024) Sonodynamic-chemotherapy synergy with chlorin e6-based carrier-free nanoparticles for non-small cell lung cancer. Journal of Materials Chemistry B, [PMID:38487900] [10.1039/D4TB00009A] |